These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11503187)

  • 21. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin ameliorates chronic renal failure-induced oxidative organ damage in rats.
    Sener G; Paskaloglu K; Toklu H; Kapucu C; Ayanoglu-Dulger G; Kacmaz A; Sakarcan A
    J Pineal Res; 2004 May; 36(4):232-41. PubMed ID: 15066047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
    Liu K; Xu H; Lv G; Liu B; Lee MK; Lu C; Lv X; Wu Y
    Life Sci; 2015 Feb; 123():78-85. PubMed ID: 25623853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model.
    Feng JX; Hou FF; Liang M; Wang GB; Zhang X; Li HY; Xie D; Tian JW; Liu ZQ
    Kidney Int; 2007 May; 71(9):901-11. PubMed ID: 17342181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative Stress in Animal Models of Acute and Chronic Renal Failure.
    Gyurászová M; Kovalčíková AG; Renczés E; Kmeťová K; Celec P; Bábíčková J; Tóthová Ľ
    Dis Markers; 2019; 2019():8690805. PubMed ID: 30886657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos.
    Hafizur RM; Momin S; Fatima N
    BMC Complement Altern Med; 2017 Apr; 17(1):227. PubMed ID: 28431540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
    Fahmi AN; Shehatou GS; Shebl AM; Salem HA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):819-30. PubMed ID: 27215580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.
    Miyata T; van Ypersele de Strihou C; Kurokawa K; Baynes JW
    Kidney Int; 1999 Feb; 55(2):389-99. PubMed ID: 9987064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
    Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferulsinaic acid attenuation of diabetic nephropathy.
    Sayed AA
    Eur J Clin Invest; 2013 Jan; 43(1):56-63. PubMed ID: 23190272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications.
    Bansal S; Chawla D; Siddarth M; Banerjee BD; Madhu SV; Tripathi AK
    Clin Biochem; 2013 Jan; 46(1-2):109-14. PubMed ID: 23103709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diltiazem attenuates oxidative stress in diabetic rats.
    Anjaneyulu M; Chopra K
    Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients.
    Kalousová M; Zima T; Tesar V; Lachmanová J
    Blood Purif; 2002; 20(6):531-6. PubMed ID: 12566668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of oxidative stress in D-serine induced nephrotoxicity.
    Orozco-Ibarra M; Medina-Campos ON; Sánchez-González DJ; Martínez-Martínez CM; Floriano-Sánchez E; Santamaría A; Ramirez V; Bobadilla NA; Pedraza-Chaverri J
    Toxicology; 2007 Jan; 229(1-2):123-35. PubMed ID: 17110013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoprotective and antioxidant role of diallyl tetrasulfide on cadmium induced renal injury: an in vivo and in vitro study.
    Pari L; Murugavel P; Sitasawad SL; Kumar KS
    Life Sci; 2007 Jan; 80(7):650-8. PubMed ID: 17125799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage.
    Sahu BD; Kuncha M; Sindhura GJ; Sistla R
    Phytomedicine; 2013 Mar; 20(5):453-60. PubMed ID: 23353054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Terminalia chebula aqueous extract on oxidative stress and antioxidant status in the liver and kidney of young and aged rats.
    Mahesh R; Bhuvana S; Begum VM
    Cell Biochem Funct; 2009 Aug; 27(6):358-63. PubMed ID: 19548245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
    Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
    Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.